Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis

International Journal of Rheumatology

Volumn 2011, Issue , 2011, Pages

  Hettema, M E ^a   Bootsma, H ^a   Graaff, R ^a   De Vries, R ^a   Kallenberg, C G M ^a   Smit, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; COLLAGEN; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; PREDNISOLONE; VASODILATOR AGENT;

ADULT; AGE; ANALYTICAL PARAMETERS; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; EXCITATION EMISSION MATRIX; FEMALE; HUMAN; HYPERTENSION; MALE; MEDGER SEVERITY SCALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM; SKIN AUTOFLUORESCENCE; SKIN FIBROSIS; SKIN PIGMENTATION; SYSTEMIC SCLEROSIS; ULTRAVIOLET A RADIATION;

EID: 81555215666     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2011/417813     Document Type: Article

References (40)

1. Generini S., Kahaleh B., Matucci-Cerinic M., Pignone A., Lombardi A., Ohtsuka T., Raynaud's phenomenon and systemic sclerosis Annali Italiani di Medicina Interna 1996 11 2 125 131 (Pubitemid 26251964)
2. Kahaleh M. B., LeRoy E. C., Autoimmunity and vascular involvement in systemic sclerosis (SSc) Autoimmunity 1999 31 3 195 214 (Pubitemid 30179202)
3. Herrick A. L., Matucci M. C., The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis Clinical and Experimental Rheumatology 2001 19 1 4 8 (Pubitemid 32203838)
4. Simonini G., Cerinic M. M., Generini S., Zoppi M., Anichini M., Cesaretti C., Pignone A., Falcini F., Lotti T., Cagnoni M., Oxidative stress in systemic sclerosis Molecular and Cellular Biochemistry 1999 196 1-2 85 91 (Pubitemid 29338782)
5. Bruckdorfer K. R., Hillary J. B., Bunce T., Vancheeswaran R., Black C. M., Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis Arthritis and Rheumatism 1995 38 8 1060 1067
6. Herrick A. L., Illingworth K. J., Hollis S., Gomez-Zumaquero J. M., Tinahones F. J., Antibodies against oxidized low-density lipoproteins in systemic sclerosis Rheumatology 2001 40 4 401 405
7. Ogawa F., Shimizu K., Muroi E., Hara T., Hasegawa M., Takehara K., Sato S., Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis Rheumatology 2006 45 7 815 818 (Pubitemid 43985368)
8. Smit A. J., Lutgers H. L., The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation Current Medicinal Chemistry 2004 11 20 2767 2784 (Pubitemid 39255562)
9. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D. M., Schmidt A. M., De Caterina R., Advanced glycation end products activate endothelium through signal-transduction receptor RAGE a mechanism for amplification of inflammatory responses Circulation 2002 105 7 816 822 (Pubitemid 34174921)
10. Hein G. E., Khler M., Oelzner P., Stein G., Franke S., The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis Rheumatology International 2005 26 2 137 141 (Pubitemid 41779823)
11. Kurien B. T., Hensley K., Bachmann M., Scofield R. H., Oxidatively modified autoantigens in autoimmune diseases Free Radical Biology and Medicine 2006 41 4 549 556 (Pubitemid 44080517)
12. Takahashi M., Suzuki M., Kushida K., Miyamoto S., Inoue T., Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis British Journal of Rheumatology 1997 36 6 637 642
13. Rodrguez-Garca J., Requena J. R., Rodrguez-Segade S., Increased concentrations of serum pentosidine in rheumatoid arthritis Clinical Chemistry 1998 44 2 250 255 (Pubitemid 28087720)
14. de leeuw K., Graaff R., de Vries R., Dullaart R. P., Smit A. J., Kallenberg C. G., Bijl M., Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus Rheumatology 2007 46 10 1551 1556 (Pubitemid 47500568)
15. Matsumoto T., Tsurumoto T., Baba H., Osaki M., Enomoto H., Yonekura A., Shindo H., Miyata T., Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods Rheumatology International 2007 28 2 157 160 (Pubitemid 350105869)
16. Meerwaldt R., Graaf R., Oomen P. H. N., Links T. P., Jager J. J., Alderson N. L., Thorpe S. R., Baynes J. W., Gans R. O. B., Smit A. J., Simple non-invasive assessment of advanced glycation endproduct accumulation Diabetologia 2004 47 7 1324 1330 (Pubitemid 39093330)
17. Meerwaldt R., Hartog J. W. L., Graaff R., Huisman R. J., Links T. P., Den Hollander N. C., Thorpe S. R., Baynes J. W., Navis G., Gans R. O. B., Smit A. J., Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients Journal of the American Society of Nephrology 2005 16 12 3687 3693 (Pubitemid 46211290)
18. Meerwaldt R., Lutgers H. L., Links T. P., Graaff R., Baynes J. W., Gans R. O. B., Smit A. J., Skin autofluorescence is a strong predictor of cardiac mortality in diabetes Diabetes Care 2007 30 1 107 112 (Pubitemid 46052507)
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis and Rheumatism 1980 23 5 581 590
20. Brevetti G., Silvestro A., Schiano V., Chiariello M., Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index Circulation 2003 108 17 2093 2098 (Pubitemid 37337585)
21. Conroy R. M., Pyrl K., Fitzgerald A. P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetire P., Jousilahti P., Keil U., Njlstad I., Oganov R. G., Thomsen T., Tunstall-Pedoe H., Tverdal A., Wedel H., Whincup P., Witheimsen L., Graham I. M., Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project European Heart Journal 2003 24 11 987 1003 (Pubitemid 36712275)
22. Valentini G., Della Rossa A., Bombardieri S., Bencivelli W., Silman A. J., D'Angelo S., Matucci Cerinic M., Belch J. F., Black C. M., Bruhlmann P., Czirjk L., De Luca A., Drosos A. A., Ferri C., Gabrielli A., Giacomelli R., Hayem G., Inanc M., McHugh N. J., Nielsen H., Rosada M., Scorza R., Stork J., Sysa A., Van Den Hoogen F. H. J., Vlachoyiannopoulos P. J., European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes Annals of the Rheumatic Diseases 2001 60 6 592 598 (Pubitemid 32493986)
23. Valentini G., Bencivelli W., Bombardieri S., D'Angelo S., Della Rossa A., Silman A. J., Black C. M., Czirjak L., Nielsen H., Vlachoyiannopoulos P. G., European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria Annals of the Rheumatic Diseases 2003 62 9 901 903 (Pubitemid 37026505)
24. Medsger T. A., Bombardieri S., Czirjak L., Scorza R., Della Rossa A., Bencivelli W., Assessment of disease severity and prognosis Clinical and Experimental Rheumatology 2003 21 3 S42 S46
25. Mulder D. J., Water T. V., Lutgers H. L., Graaff R., Gans R. O., Zijlstra F., Smit A. J., Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations Diabetes Technology and Therapeutics 2006 8 5 523 535 (Pubitemid 44946877)
26. Graaff R., Meerwaldt R., Lutgers H. L., Baptist R., De Jong E. D., Zijp J. R., Links T. P., Smit A. J., Rakhorst G., Instrumentation for the measurement of autofluorescence in the human skin Advanced Biomedical and Clinical Diagnostic Systems III January 2005 San Jose, Calif, USA 111 118 Proceedings of SPIE (Pubitemid 40954219)
27. De Leeuw K., Sanders J. S., Stegeman C., Smit A., Kallenberg C. G., Bijl M., Accelerated atherosclerosis in patients with Wegener's granulomatosis Annals of the Rheumatic Diseases 2005 64 5 753 759 (Pubitemid 40559304)
28. Kaloudi O., Basta G., Perfetto F., Bartoli F., Del Rosso A., Miniati I., Conforti M. L., Generini S., Guiducci S., Abbate R., Pignone A., Castellani S., Livi R., De Caterina R., Matucci-Cerinic M., Circulating levels of N -(carboxymethyl)lysine are increased in systemic sclerosis Rheumatology 2007 46 3 412 416 (Pubitemid 46344651)
29. Meerwaldt R., Links T., Graaff R., Thorpe S. R., Baynes J. W., Hartog J., Gans R., Smit A., Simple noninvasive measurement of skin autofluorescence Annals of the New York Academy of Sciences 2005 1043 290 298 (Pubitemid 41123918)
30. Valentini G., Cerinic M. M., Disease-specific quality indicators, guidelines and outcome measures in scleroderma Clinical and Experimental Rheumatology 2007 25 6, supplement 47 S159 S162 (Pubitemid 350167902)
31. Coughlan M. T., Thallas-Bonke V., Pete J., Long D. M., Gasser A., Tong D. C. K., Arnstein M., Thorpe S. R., Cooper M. E., Forbes J. M., Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 2007 148 2 886 895 (Pubitemid 46143188)
32. Forbes J. M., Thorpe S. R., Thallas-Bonke V., Pete J., Thomas M. C., Deemer E. R., Bassal S., El-Osta A., Long D. M., Panagiotopoulos S., Jerums G., Osicka T. M., Cooper M. E., Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy Journal of the American Society of Nephrology 2005 16 8 2363 2372 (Pubitemid 41725054)
33. Forbes J. M., Thomas M. C., Thorpe S. R., Alderson N. L., Cooper M. E., The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes Kidney International Supplement 2004 66 92 S105 S107 (Pubitemid 43361443)
34. Forbes J. M., Cooper M. E., Thallas V., Burns W. C., Thomas M. C., Brammar G. C., Lee F., Grant S. L., Burrell L. A., Jerums G., Osicka T. M., Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy Diabetes 2002 51 11 3274 3282 (Pubitemid 35246974)
35. Miyata T., van Ypersele de Strihou C., Ueda Y., Ichimori K., Inagi R., Onogi H., Ishikawa N., Nangaku M., Kurokawa K., Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms Journal of the American Society of Nephrology 2002 13 10 2478 2487
36. Bev R., Hulejov H., Braun M., tork J., Collagen degradation products and proinflammatory cytokines in systemic and localized scleroderma Folia Biologica 2007 53 2 66 68 (Pubitemid 46546780)
37. Dorrian C. A., Cathcart S., Clausen J., Shapiro D., Dominiczak M. H., Factors in human serum interfere with the measurement of advanced glycation endproducts Cellular and Molecular Biology (Noisy-le-Grand, France) 1998 44 7 1069 1079
38. Hricik D. E., Wu Y. C., Schulak J. A., Friedlander M. A., Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation Clinical Transplantation 1996 10 6, part 1 568 573 (Pubitemid 27010902)
39. Scheja A., Wildt M., Wollheim F. A., kesson A., Saxne T., Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement Rheumatology 2000 39 10 1110 1113
40. Zurita-Salinas C. S., Krtzsch E., Daz De Len L., Alcocer-Varela J., Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis Rheumatology International 2004 24 5 283 290 (Pubitemid 39286910)